The biotech space saw a flurry of activity last week, with coronavirus-related news, conference presentations and IPOs. Negative clinical readouts led to some strong selling in...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Israel stocks higher at close of trade; TA 35 up 0.05%
OPKO Health ran into SEC-related issues in 2018 and its stock price has plummeted since. OPKO has a long history of operating losses, but it has the potential t

Company News for June 2, 2020

01:42pm, Tuesday, 02'nd Jun 2020
Companies in the news are: MYOV, ITRM, COTY, OPK

71 Biggest Movers From Yesterday

08:39am, Tuesday, 02'nd Jun 2020
Q1 2020 OPKO Health Inc Earnings Call
OPKO Health (OPK) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is (OPK) Outperforming Other Medical Stocks This Year?
Details the CEO buys this week for the following companies: OPKO Health, Orion Engineered Carbons SA and Inari Medical Continue reading...

A Look Into OPKO Health's Price Over Earnings

02:35pm, Monday, 01'st Jun 2020
In the current session, OPKO Health Inc. (NASDAQ: OPK) is trading at $2.42, after a 6.14% increase. Over the past month, the stock increased by 5.22%, and in the past year, by 22.22%. With performance
OPKO Health, Inc. (OPK) today announced that the U.S. Food and Drug Administration (FDA) has authorized OPKO to undertake a Phase 2 trial with RAYALDEE® as a treatment for patients with mild-to-moder
Israel stocks higher at close of trade; TA 35 up 1.04%
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE